Advisory Research Inc Gilead Sciences, Inc. Transaction History

Advisory Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $83,108 - $90,673	-1,124 Reduced 22.79%	3,809 $285,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $374,957 - $427,691	4,933 New	4,933 $380,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $221,142 - $269,596	-3,036 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $20,989 - $24,638	295 Added 10.76%	3,036 $217,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $197,653 - $234,273	2,741	2,741 $222,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.